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Nonsyndromic cleft lip with or without cleft palate (NSCL/P) is one of the most common congenital facial defects, with
an incidence of 1 in 700–1,000 live births among individuals of European descent. Several linkage and association studies
of NSCL/P have suggested numerous candidate genes and genomic regions. A genomewide linkage analysis of a large
multigenerational family (UR410) with NSCL/P was performed using a single-nucleotide–polymorphism array. Non-
parametric linkage (NPL) analysis provided significant evidence of linkage for marker rs728683 on chromosome 18q21.1
( and ; nonparametric and ). Parametric linkage analysis with a dom-NPLp 43.33 Pp .000061 LODp 3.97 Pp .00001
inant mode of inheritance and reduced penetrance resulted in a maximum LOD score of 3.61 at position 47.4 Mb on
chromosome 18q21.1. Haplotype analysis with informative crossovers defined a 5.7-Mb genomic region spanned by
proximal marker rs1824683 (42,403,918 bp) and distal marker rs768206 (48,132,862 bp). Thus, a novel genomic region
on 18q21.1 was identified that most likely harbors a high-risk variant for NSCL/P in this family; we propose to name
this locus “OFC11” (orofacial cleft 11).
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Cleft lip and palate are birth defects that affect the upper
lip and the roof of the mouth. Nonsyndromic cleft lip
with or without cleft palate (NSCL/P) is one of the most
common congenital craniofacial birth defects, affecting 1
in 700–1,000 newborns in the United States each year.1
Its highest prevalence rates are in Native Americans and
Asians.2–4 Nonsyndromic familial NSCL/P represents al-
most half of facial malformations; the cases can be spo-
radic or inherited as an autosomal dominant trait. On the
other hand, 1400 syndromes, including numerous chro-
mosomal anomalies, may include a facial cleft as one of
the manifestations. Some of the common syndromes and/
or anomalies associated with such clefting include van der
Woude (MIM 119300), Apert (MIM 101200), Meckel (MIM
249000), Treacher Collins (MIM 154500), and Zlotogora-
Ogur (MIM 225060) syndromes; however, the genes mu-
tated in these disorders are not responsible for NSCL/P.5
Recent reports suggest that several genes on various chro-
mosomal regions have pathogenic mutations associated
with NSCL/P, including LHX8 (MIM 604425) on 1p31.1,
SKI (MIM *164780) on 1p36.3, MTHFR (MIM *607093) on
1p36.3, IRF6 (MIM *607199) on 1q32-q41, TGFB2 on 1q41,
TGFA (MIM *190170) on 2p13.3, GLI2 (MIM *165230) on
2q14.2, SATB2 (MIM *608148) on 2q32-q33, SUMO1 (MIM
*601912) on 2q33.1, P63 (MIM *603273) on 3q27-q29,
MSX1 (MIM *142983) on 4p16.3-p16.1, SPRY1 (MIM
*602465) on 4q28.1, MSX2 (MIM *123101) on 5q34-q35,
F13A1 (MIM 134570) on 6p25.3-p24.3, TGFBR1 (MIM
*190181) on 9q33-q34, FOXE1 (MIM *602617) on
9q22.33, PVRL1 (MIM *600644) on 11q23-q24, SPRY2
(MIM *602466) on 13q31.1, TGFB3 (MIM *190230) on
14q24.3, JAG2 (MIM *602570) on 14q32.33, GABRB3
(MIM *137192) on 15q11.2-q12, RARA (MIM *180240) on
17q21.1, BCL3 (MIM *109560) on 19q13.31, TGFB1 (MIM
*190180) on 19q13.2, TBX1 (MIM *602054) on 22q11.21,
and PHF8 (MIM *300560) on Xp11.26–13; however, none
of these seem to be a common locus for the majority of
sporadic or familial cases of NSCL/P.14–16
Various independent association and linkage studies of
different populations have identified 10 loci with evidence
of linkage for syndromic and/or nonsyndromic orofacial
cleft (OFC): on 6p24.3 (OFC1 [MIM 119530]), 2p13 (OFC2
[MIM 602966]), 19q13 (OFC3 [MIM 600757]), 4q21-q31
(OFC4 [MIM 608371), 4p16.1 (OFC5 [MIM 608874]), 1q32-
q41 (OFC6 [MIM 608864]), 11q23-q24 (OFC7 [MIM
600644]), 3q27 (OFC8 [MIM 129400]), 13q33.1-34 (OFC9
[MIM 610361]), and 2q32.2-q33 (OFC10 [MIM 601912]).
Pathogenic mutations have been identified in 4 of these
10 loci: MSX1 on 4p16.1, IRF6 on 1q32-q41, PVRL1 on
11q23-q24, and TP73L on 3q27.17–20 Increased incidence
of clefts associated with chromosomal aberrations involv-
ing chromosomes 13 and 18 have also been reported.21,22
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Figure 1. Pedigree of family UR410 with NSCL/P. Affected individuals are shown with blackened symbols, and unaffected individuals
are shown with unblackened symbols. Samples included in the analysis are numbered below their pedigree symbols. A dot in the center
of a symbol indicates an individual who is an obligate carrier and produced affected children with NSCL/P. BCLPpbilateral cleft lip
and cleft palate; UCLPpunilateral cleft lip and cleft palate; BCLpbilateral cleft lip; UCLpunilateral cleft lip.
A genomewide linkage analysis was performed on an
extended American family (UR410) of self-reported Eu-
ropean origin with NSCL/P and likely autosomal domi-
nant mode of inheritance. The family initially was tested
for linkage to loci reported elsewhere to be candidates for
autosomal dominant forms of NSCL/P (OFC4). Markers
analyzed by Beiraghi et al.23 for the OFC4 locus on chro-
mosome 4q provided weak evidence of linkage (LOD score
!2.3). The present analysis with use of SNP markers pro-
vides significant evidence of a susceptibility locus on a
genomic region of ∼5.7 Mb on chromosome 18q21.1.
The six-generation NSCL/P-affected family (UR410) with
probable autosomal dominant inheritance was first ascer-
tained in Switzerland; however, a branch of 30 individuals
residing in the United States has extended the pedigree
reported by Ward et al.24 Of the 52 individuals in this
family, 11 (7 males and 4 females) showed NSCL/P pheno-
types, ranging from unilateral to bilateral NSCL/P. There
were no other associated anomalies observed in the in-
dividuals of this family. Informed consent was obtained
from all subjects who participated in the study, and blood
samples were collected from all cooperating family mem-
bers. Samples from a total of 27 individuals were used for
the linkage analysis: 9 affected individuals, 4 obligate car-
riers, and 14 apparently unaffected individuals (fig. 1).
DNA from peripheral-blood samples was isolated using
DNA-extraction kits. A genomewide genotyping was un-
dertaken using GeneChip Mapping 10K XbaI Array con-
taining 10,555 SNPs. These SNP markers are equally dis-
tributed in the genome, with mean intermarker distances
of 250 kb and an average heterozygosity of 0.38 (Affymet-
rix). The assay was done using 250 ng of genomic DNA,
and 199% of the SNPs were determined unequivocally for
each sample. Scanned images were processed with Affy-
metrix Micro Array Suite Software, and data were analyzed
with GDAS v2 software. PedCheck was used for the de-
tection of any Mendelian incompatibility of genotypes.25
SNP genotype data were imported into the linkage-anal-
ysis programs GENEHUNTER26 and MERLIN.27 In the ini-
tial genome scan, evidence of linkage was assessed with
a nonparametric, penetrance-independent, affected-only,
and allele-sharing analysis (NPL score). With use of MER-
LIN, one can convert this into a nonparametric LOD score
(LOD*) by maximizing the likelihood with respect to a
scalar parameter, d, that measures the amount of excess
sharing of identical-by-descent alleles among affected rel-
atives (with corresponding to the null hypothesisdp 0
of no linkage28). We used the Sall scoring function
26,29 and
the exponential allele-sharing model to generate the rel-
evant linkage statistic.
When significant evidence of linkage was found by ex-
ceeding the predetermined threshold ( ), two-pointP ! .01
as well as multipoint LOD scores maximized over various
plausible genetic model parameters (MOD-score analy-
sis) of the entire pedigree were performed, using a GENE-
HUNTER_MODSCORE analysis package. The map order
and intermarker distances between SNPs were based on
data from the National Center for Biotechnology Infor-
mation (build 35.1). To evaluate the false-positive rate of
linkage, simulations were performed to evaluate the re-
sults with use of empirical P values. The simulations were
designed to match the observed data in marker density
and informativeness, pedigree structure, and individual
phenotypes. We generated 10,000 replicate data sets under
the null hypothesis of no linkage, to estimate the empir-
ical P value. On the basis of our simulations, the empirical
threshold for genomewide significance at the 5% level was
set at . Putative haplotypes containing theNPLp 42.12
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Table 1. Two-Point LOD Scores between NSCL/P in family UR410 and
Polymorphic Markers from Known Candidate Genomic Region on
Chromosome 4q
Marker
LOD at vp
Mapping
Position
(cM).00 .01 .05 .10 .20 .30 .40
D4S193 9.86 3.12 .59 .28 .76 .71 .43 117.06
D4S1612 10.37 3.98 1.33 .31 .44 .59 .42 124.45
D4S194 4.73 1.85 .70 .28 .01 .02 .00 126.15
D4S2975 3.14 .46 .24 .47 .51 .34 .12 126.71
D4S1615 1.69 .77 1.27 1.31 1.08 .69 .26 128.31
D4S2307 3.21 .45 .76 1.12 1.19 .96 .55 129.92
D4S429 10.72 3.30 1.35 .62 .09 .00 .01 131.00
D4S3039 6.96 1.90 .62 .18 .10 .10 .01 132.72
D4S175 3.36 .45 1.64 1.97 1.93 1.52 .87 134.74
D4S2939 3.58 1.94 .72 .17 .20 .20 .09 142.24
D4S192 3.11 .55 .16 .43 .60 .54 .34 143.31
D4S424 1.22 .45 .99 1.10 1.00 .76 .42 144.56
D4S2998 9.60 3.87 1.23 .23 .50 .63 .44 145.98
D4S1586 5.77 1.98 .66 .16 .19 .25 .17 147.06
D4S3008 .63 .62 .59 .54 .42 .30 .16 152.98
D4S3021 7.44 5.00 2.94 1.99 1.03 .51 .19 154.63
D4S2631 7.21 3.25 1.31 .59 .07 .06 .05 155.75
D4S413 11.86 3.41 1.46 .73 .19 .03 .00 157.99
D4S3033 9.32 2.55 .09 .70 1.04 .84 .42 161.04
NOTE.—Scores were calculated under a dominant model with 75% penetrance and .0001
disease-allele frequency.
disease-causing loci were determined by using the critical
recombinants across the affected family members, with
use of SIMWALK and GENEHUNTER.
Linkage analysis of tightly linked loci can lead to an
excess of false-positive results if the markers are in strong
linkage disequilibrium (LD) and parents are not available
for genotyping.30,31 Therefore, the impact of LD on LOD
scores was reassessed at the linked regions, with use of
two approaches. First, MERLIN was used to accommodate
marker-marker LD in both parametric and nonparametric
analyses, by organizing closely located adjacent markers
into clusters. Although many studies have shown that the
extent and distribution of LD are variable throughout the
genome, in most cases, significant LD does not influence
markers separated by 10.1 cM in outbred populations.32–
34 However, to be conservative, markers within 0.2 cM in
a cluster were used. Second, SNPLINK35 was used to cal-
culate LD between markers, and the LD was then removed
by considering each set of markers in LD (defined as “sets
in which each consecutive marker pair in the set is found
to be in LD”) and by retaining one SNP from each set,
chosen as the middle SNP from the set. Linkage was then
recalculated using the new LD-free set of markers. We used
LD values 10.7 and 10.4 for D′ and r2, respectively, to define
significant LD, as suggested elsewhere.36,37
Before this genomewide analysis, 19 polymorphic mi-
crosatellite markers on chromosome 4q (OFC4) had been
genotyped in the region from 117.06 cM to 161.04 cM
(GDB Human Genome Database). It was suggested that
chromosome 4q was involved in NSCL/P, because a pre-
vious limited study23 of a small branch of the UR410
family had detected LOD scores of 2.27 and 1.93 for
markers D4S175 and D4S192, respectively. Linkage
analysis was performed using LINKAGE, under the as-
sumption of an autosomal dominant inheritance with
reduced penetrance.
The linkage analysis of and haplotype data about chro-
mosome 4q determined using samples from the extended
pedigree excluded the published candidate genomic re-
gion23 (table 1). The genomewide linkage scan with use
of an NPL analysis provided significant evidence of link-
age for an NSCL/P locus (OFC11) at and around marker
rs728683 on chromosome 18q21.1 ( ;NPLp 43.33 Pp
). With use of simulations (see above), this value.000061
is equivalent to a genomewide empirical P value of .012.
We also converted these NPL values to nonparametric
LOD* scores,28 maximizing over d. The peak linkage cor-
responds to the Kong and Cox28 LOD* score of 3.97, with
. These data were also supported by subsequentPp .00001
parametric linkage analysis, with a dominant mode of in-
heritance and reduced penetrance. The maximum mul-
tipoint LOD score of 3.61 at position 47.4 Mb on chro-
mosome 18 was observed. Twenty-three SNP markers,
spanning a region of ∼8.2 cM (rs1824683–rs724349),
showed parametric LOD scores from 3.61 ( ;NPLp 43.30
) to 2.92 ( ; ) (tablePp .000061 NPLp 17.33 Pp .000244
2). The best-fitted parametric model that was used for ob-
taining the optimum linkage results was incomplete dom-
inance with 65% penetrance and disease-allele frequency
of 0.0001. No additional peak with a statistically signifi-
cant LOD score was found in the genome (fig. 2). Haplo-
type analysis for the 18q21.1-linked region was performed
using 27 informative SNP markers. Informative crossovers
in affected individuals IV-10 (4021) and V-3 (4009), be-
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Table 2. Parametric-Linkage and NPL Scores for the Peak
Region at Chromosome 18q21.1
SNP
Position
Genome Scan of the
NSCL/P-Affected Family
Genetic
(cM)
Physical
(bp)
Parametric
LOD
Nonparametric
LOD
NPL P
rs726131 65.641 42,118,566 .55 10.53 .000656
rs1824683 66.057 42,403,918 3.48 34.40 .000244
rs328149 66.087 42,424,469 3.51 36.10 .000244
rs645631 66.203 42,505,993 3.61 42.82 .000153
rs1073744 66.204 42,506,272 3.61 42.81 .000153
rs953291 67.077 43,124,497 3.61 42.78 .000153
rs1944574 68.548 43,979,261 3.61 42.82 .000153
rs953570 68.567 43,988,463 3.61 42.82 .000153
rs1944584 68.667 44,035,980 3.61 42.82 .000153
rs1398193 68.885 44,241,137 3.61 42.83 .000153
rs1877412 68.885 44,241,673 3.61 42.83 .000153
rs1943984 70.873 45,477,909 3.61 42.76 .000153
rs1985467 71.431 45,928,259 3.61 42.82 .000153
rs1822466 71.519 45,999,664 3.61 42.83 .000153
rs1373185 71.519 45,999,849 3.61 42.83 .000153
rs768360 71.542 46,018,071 3.61 42.83 .000153
rs2006747 71.795 46,222,356 3.61 42.83 .000153
rs728682 71.966 46,349,352 3.61 42.83 .000153
rs2969972 71.989 46,362,761 3.61 42.84 .000061
rs1822458 72.264 46,528,403 3.61 42.94 .000061
rs1941962 72.892 46,999,467 3.61 43.17 .000061
rs1369766 73.228 47,272,878 3.61 43.30 .000061
rs728683 73.339 47,362,995 3.61 43.33 .000061
rs724349 74.247 48,019,014 2.92 17.33 .000244
rs959655 74.477 48,132,862 .23 10.74 .000610
rs768207 74.477 48,132,968 .04 10.73 .000610
NOTE.—The model used for parametric analysis was incomplete dom-
inance with 65% penetrance and a disease-allele frequency of .0001.
tween rs1824683/rs328149 and rs768207/rs768206, respec-
tively, defined the NSCL/P candidate region of 5.7 Mb,
bordered by proximal marker rs1824683 (physical map
position 42,403,918 bp) and distal marker rs768206 (phys-
ical map position 48,132,862 bp) (fig. 3).
To assess the impact of LD on linkage, we first used
markers within 0.1–0.2 cM of each other in a cluster and
estimated the linkage scores. Several clusters of 2–6 SNPs
demonstrated LD. With the assumption of complete LD
within the cluster, MERLIN uses population haplotype fre-
quencies in the calculation of linkage. Interestingly, at
chromosome 18, the LOD and NPL scores were virtually
the same, especially for the significant markers. We also
recalculated the linkage scores by removing the redundant
SNPs ( or ), using SNPLINK, and arrived at′ 2D 1 0.7 r 1 0.4
almost similar results.
The etiology of OFCs is complex, related to both genetic
and environmental factors.2,38 Although there have been
a number of studies undertaken to identify the genetic
variations responsible for NSCL/P, the results have not
been consistent among populations, and no single sus-
ceptibility gene has been identified to date that plays a
major role in this disorder.39–44 The majority of these re-
ports used small nuclear families; however, there are a few
exceptional large multigenerational families with both an
autosomal dominant and autosomal recessive inheritance
of NSCL/P that gave significant evidence of linkage to
chromosomes 13q,45 17p,46 and multiple loci.47 Previous
studies of a subset of pedigree UR410 suggested evidence
of linkage on 4q; however, the present study, which in-
cludes 19 additional genotyped individuals (2 affected),
fails to confirm this region (LOD score !2.3). The previous
data were also considered to be a false-positive result by
two independent studies.42,48 We report here linkage anal-
ysis, with use of an SNP array containing ∼10,000 SNP
markers, that provided significant evidence of a novel sus-
ceptibility locus on a genomic region of 5.7 Mb on chro-
mosome 18q21.1.
Several genomewide linkage studies conducted using
multiplex families of various ethnic origins showed evi-
dence of linkage at chromosome 18; however, these sug-
gested regions either do not include the present locus or
do not have statistically significant results.39,40,44,49 The ge-
nome-scan meta-analysis conducted by Marazita et al.43
of 388 extended multiplex families with NSCL/P from
seven diverse populations yielded positive evidence at
multiple loci, including weak evidence at the chromosome
18q21.1 region. Furthermore, the study suggested SMAD2
as a candidate in the mapped genetic interval.
A whole-genome scan, performed using a high-density
SNP genotyping assay conducted by Radhakrishna et al.,45
of two large Indian families provided suggestive evidence
of linkage on chromosome 18q21.1 and strong evidence
on chromosome 13q33.1-34. The SNP marker (rs959655)
that gave the highest NPL peak ( ; )NPLp 3.64 Pp .0066
on chromosome 18 in the previous study45 is also sup-
ported by parametric LOD score. This SNP marker is in
the vicinity of the genetic interval mapped in the present
study. Several studies have also found that genetic var-
iation in IRF6 contributes to the development of NSCL/
P50–52; however, in the present study, we did not observe
any positive linkage.
Numerous reports indicate that chromosome 18–related
anomalies are associated with increased incidence of
NSCL/P, including deletion of 18q53–57 and full or partial
trisomy 18 involving the region 18q21.21,22,58–69 Niedrist et
al.22 analyzed 352 cases of trisomy 18 from northeastern
Switzerland and found that 14% of the subjects had facial
clefts. Schinzel et al.70 reported three subjects with the 18q
syndrome associated with various developmental anom-
alies and cleft palate. An isochromosome 18q in a fetus
with congenital megacystis, growth retardation, and cleft
lip and palate was reported by Chen et al.59 Partial deletion
of 18q in a patient with bilateral complete cleft lip was
reported by Fujimoto et al.68 Cody et al.55 analyzed 42
individuals with deletions of 18q and observed several
subjects with craniofacial abnormalities, including NSCL/
P, associated with breakpoints at 18q21.1, 18q21, and
18q21.2.
The 5.7-Mb interval containing the locus for NSCL/P on
chromosome 18q21.1 contains 36 annotated transcripts
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Figure 2. Multipoint linkage analysis with use of NPL in the genomewide scan of multigenerational family UR410 with NSCL/P. In
the upper panel, the X-axis represents the chromosome location for the 22 autosomes, and the Y-axis represents the NPL score. The
highest peak is on chromosome 18q21.1. In the lower panel, the X-axis shows chromosome location for the 22 chromosomes, and the
Y-axis shows the location score, calculated using GENEHUNTER software. The maximal LOD score of 3.61 is observed around marker
rs728683.
(Ensembl), including several genes implicated in develop-
mental or pathological events in craniofacial birth defects.
Candidate genes include protein inhibitor of activated
STAT2 (PIAS2 [MIM 603567]), mothers against decapen-
taplegic and homologs of the Drosophila (MAD) genes
(SMAD2 [MIM 601366], SMAD4 [MIM 600993], and
SMAD7 [MIM 602932]). Recent reports suggested that the
members of the transforming growth factor-b (TGF-b) su-
perfamily that function in the embryonic palate are me-
diated through the SMAD-signaling system.71 SMAD pro-
teins play a key role in intracellular TGF-b signaling, and
mutations in the TGF-b pathway confer resistance to
growth inhibition by TGF-b.72 The TGF-b3–knockoutmouse
resulted in cleft palate due to failure of palatal shelf fu-
sion,73–75 and polymorphisms in the gene for TGF-b3 have
been linked to the development of cleft palate in humans.6
Haplotype analysis with critical recombination events
allowed us to define a 5.7-Mb disease interval delimited by
proximal SNP marker rs824683 (map position 42,403,918
bp) and distal SNP marker rs768206 (map position
48,133,056 bp). The critical interval of the 11th OCF locus
(OFC11) could not be further reduced, since additional
members of the family were not available. Haplotype anal-
ysis identified the risk haplotype shared by all affected
individuals that was not found in any of the unrelated
unaffected spouses. Since NSCL/P demonstrates reduced
penetrance, all unaffected parents (subjects 4001, 4004,
4030, and 4032) who had affected children shared the
affected haplotype. Therefore, we speculate that individ-
uals 4018, 4020, 4024, and 4027 with normal phenotype
and “at risk” haplotypes may also be at risk of having
affected children. The haplotype data also support the au-
tosomal dominant mode of inheritance in this family. Var-
iation in the phenotypic expression—that is, the range
from bilateral to unilateral NSCL/P—in members of the
same pedigree (UR410) indicates that the genetic variation
responsible for these abnormalities at a single locus might
have variable phenotypic expression. Few of the positional
candidate genes are currently being screened for a possible
role in the pathogenesis of NSCL/P, but the results are
inconclusive at present. We are also pursuing cytogenetic
analysis and array comparative-genomic hybridization
that may reveal microdeletions and/or duplications. In
summary, this study demonstrates the power of using mul-
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Figure 3. Genotypes and haplotypes of chromosome 18q21.1 SNP markers are shown below selected individuals of family UR410.
Haplotypes associated with affected status are shown in red. Haplotype analysis indicated that the cosegregating segment of the NSCL/P
locus is flanked proximally by marker rs1824682 (position 42403918) and distally by marker rs959655 (position 48132862) on chromosome
18q21.1.
tigenerational families in the analysis of complex traits.
Identification of the pathogenic genetic variation would
potentially provide significant insights into the molecular
mechanisms underlying the etiology of NSCL/P.
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